Preparation method and medical application of cervical carcinoma associated trichina antigen antibody
An antigen-antibody, cervical cancer technology, applied in the direction of antibodies, anti-tumor drugs, anti-animal/human immunoglobulins, etc., can solve the problem of unclear anti-tumor active ingredients, and achieve the effect of easy preparation and industrialization
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] Preparation of mouse anti-trichinella and cervical cancer Hela cell-associated antigen antibody:
[0031] The ELISA method was used to find that the soluble antigen of Trichinella spiralis could cross-react with the anti-Hela cell antibody, and preliminarily determined the antigen related to the immune cross-reaction between Trichinella spiralis and Hela cells. Then, determine the molecular weight of the antigen associated with Trichinella spiralis and Hela cells according to SDS-PAGE and Western (see attached figure 1 ), collect the 40KDa Trichinella spiralis and cervical cancer Hela cell-associated antigen protein, and measure the protein value of the collected Trichinella spiralis and cervical cancer Hela cell-associated antigen with a protein quantification kit. Immunize BalB / C mice after emulsification in Freund's adjuvant (subcutaneous immunization). After 10 days, after emulsifying with 100 μg antigen and the same amount of incomplete Freund's adjuvant, the sec...
Embodiment 2
[0033] Mouse anti-Hela cells and trichinella-related antigen antibody serum preparation:
[0034] The ELISA method was used to find that the soluble antigen of Hela cells could cross-react with the anti-T. Then, according to SDS-PAGE and Western to determine the molecular weight of the antigen associated with Hela cells and Trichinella spiralis (see attached figure 1 ), collect Hela cells and the 55KDa related protein of the Trichinella spiralis-associated antigen, quantify the obtained Hela cell antigen protein, emulsify 100 μg of the antigen with the same amount of complete Freund’s adjuvant, and immunize the BalB / C small mice (subcutaneous immunization). After 10 days, after emulsifying with 100 μg antigen and the same amount of incomplete Freund's adjuvant, the second immunization was also carried out, and the third immunization was carried out one week later. After the second and third immunizations, blood was collected from the tail vein of the mice to measure the pot...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com